Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.

J Bone Miner Res. 2019 Dec;34(12):2220-2228. doi: 10.1002/jbmr.3853.

Anastasilakis AD, Papapoulos SE, Polyzos SA, Appelman-Dijkstra NM, Makras P.